Trends in use of sodium-glucose cotransporter 2 inhibitors among people with type 2 diabetes following hospitalisation with heart failure: A population-based study.

Summary: Imagine you have type 2 diabetes and just went to the hospital for heart failure. There is a great group of medicines called SGLT2 inhibitors that can help protect your heart and kidneys. Doctors looked at records for almost 19,000 patients to see if they got this medicine after leaving the hospital.

The good news? The use of this medicine went up 13 times over seven years. The bad news? Only about 13 out of 100 people actually got it by 2021. Older patients and those with kidney problems were even less likely to get it. Doctors need to do a better job of giving this helpful medicine when patients go home from the hospital.